STABLE TRANSDERMAL PHARMACEUTICAL DRUG DELIVERY SYSTEM COMPRISING RIVASTIGMINE

摘要

The present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which is free from an antioxidant. In particularly, the present invention relates to a stable transdermal pharmaceutical drug delivery system of rivastigmine or a pharmaceutically acceptable salt thereof, which provides an enhanced absorption of drug through skin, and remains stable during a longer storage period. In addition, the present invention relates to a method of treatment of mild to moderate dementia of alzheimer's type and mild to moderate dementia of parkinson's type diseases.